Explorer les evidences

5 150 mosquitoesFrom the released mosquitoes, 5150 mosquitoes (2621 males and 2529 females) of An. arabiensis, An. funestus and An. gambiae were recaptured on the attractancy traps.

Kenyapaludismepublié 2023PloS onePubMeddocument de 2 observations

55,7 %The proportion of vitamin D deficiency was 55.7% among HAART-experienced participants.

KenyaVIH/sidapublié 2024BMC infectious diseasesPubMeddocument de 10 observations

20 %Perinatal HIV transmission in Kenya declined from 20% to 10% between 2010 and 2017.

KenyaVIH/sidaobservé 2010 to 2017publié 2024PLoS medicineeurope_pmcdocument de 5 observations

41 %The pooled prevalence of persistent respiratory symptoms among individuals who completed treatment for pulmonary TB in low- and middle-income countries was 41.0%.

Kenyapersistent respiratory symptoms · post-TB lung disease · tuberculosepublié 2022PLOS global public healtheurope_pmcdocument de 11 observationsDOI 10.1371/journal.pgph.0000805

38 %In a phase 2b trial in Ghana and Kenya, vaccine efficacy of the RTS,S malaria vaccine against clinical malaria (all episodes) at month 32 post-dose 1 ranged from 38% (95% confidence interval: 24%–49%) to 53% (95% confidence interval: 42%–62%).

Ghana · Kenyapaludismepublié 2024The Journal of infectious diseasesPubMeddocument de 9 observations

24 %Post-training, there was a 24% increase in knowledge scores related to insulin administration.

Kenyadiabetic ketoacidosis (DKA)publié 2025BMC medical educationPubMeddocument de 8 observations

76,35 %Anopheles funestus mosquitoes were the predominant vectors at 76.35% of all larvae collections (N = 148).

Kenyapaludismeobservé June 2019publié 2025Malaria journalPubMeddocument de 9 observations

7,9 %With an optimal cut-off ≥ 7, the simplified FINDRISC had a positive predictive value (PPV) of 7.9% for detecting undiagnosed diabetes.

Kenyadiabète (non précisé)publié 2023PloS onePubMeddocument de 6 observations

65 %Of those screened for PrEP eligibility, 65% of adolescent girls and young women (AGYW) were ineligible.

KenyaVIH/sidaobservé February 2017 to December 2019publié 2020Journal of the International AIDS SocietyPubMeddocument de 13 observations

The most common malaria comorbidities were chest infections, diarrhoea, and anaemia.

Kenyaanémie · chest infections · diarrhée · paludismeobservé June 2016 to May 2017publié 2021Malaria journalPubMeddocument de 11 observations

37 %At Rota Dispensary, the positivity rate by rapid diagnostic test (RDT) was 37%.

Kenyapaludismepublié 2020Malaria journalPubMeddocument de 17 observations

20 %La fréquence de la neuropathie périphérique était de 20 % chez les personnes vivant avec le VIH au Kenya selon l'étude de Cettomai D et al (2010).

KenyaVIH/sidaobservé 2010HAL · Unilimdocument de 747 observations

0,48 hazard_ratioEarly post-operative infection was associated with delayed healing in both HIV-positive and HIV-negative men (HR 0.48, 95% CI 0.23–1.00).

KenyaVIH/sidapublié 2013PloS oneeurope_pmcdocument de 6 observations

100 %All 67 Cryptococcus neoformans isolates tested were susceptible to amphotericin B, voriconazole, and ravuconazole.

Kenyaméningite cryptococciquepublié 2011Mycoseseurope_pmcdocument de 5 observationsDOI 10.1111/j.1439-0507.2010.01946.x

6 300 000 testsMalaria rapid diagnostic tests showed the highest annual test volumes of 6.3 to 8.0 million in Kenya from 2018 to 2020.

Kenyapaludismeobservé 2018-2020publié 2024BMJ openPubMeddocument de 6 observations

8,9 adjusted_odds_ratioDiscontinuing antiretroviral treatment for 2 weeks or more significantly increases the risk of ART failure, with an adjusted odds ratio of 8.9.

KenyaVIH/sidapublié 2017African Journal of Health SciencesOpenAlexdocument de 8 observations

2,09 aPRMale partner controlling behavior was significantly associated with a higher prevalence of intimate partner violence in the past year among women with HIV in serodifferent relationships in Nairobi, Kenya, with an adjusted prevalence ratio of 2.09.

KenyaVIH/sidapublié 2022PloS onePubMeddocument de 8 observations

23,6 %Resistance to isoniazid (INH) among HIV-positive tuberculosis patients in Western Kenya was 23.6%.

Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 23 observations

7 children7 of the 26 Kenyan children had weak and brief antibody responses to PIESAs.

Kenyapaludismepublié 2003The Journal of infectious diseaseseurope_pmcdocument de 4 observationsDOI 10.1086/373994

1,21 %Hepatitis C virus (HCV) accounted for 1.21% of discarded blood units due to transfusion transmissible infections at the Kwale Satellite Blood Transfusion Centre in Kenya from 2018 to 2022.

Kenyahépatite Cobservé 2018-2022publié 2024BMC public healthPubMeddocument de 7 observations

193,3 EU/mLOne month post dose 3, anti-CS geometric mean antibody concentrations were 193.3 EU/mL in RTS,S/AS01-vaccinated HIV-infected children.

KenyaVIH/sidapublié 2020Vaccineeurope_pmcdocument de 7 observations

87,5 %Serious adverse events were reported for 87.5% of HIV-infected children in the C3C group.

KenyaVIH/sidapublié 2020Vaccineeurope_pmcdocument de 7 observations

4,5 %Men in Kenya have an HIV prevalence rate of 4.5%.

KenyaVIH/sidapublié 2025AIDS research and therapyPubMeddocument de 6 observations

39 %Only 39% of individuals with fever in the last two weeks took any action to treat the fever.

Kenyafeverobservé 2009publié 2011Malaria journaleurope_pmcdocument de 10 observations

650,6 cells/mm3The median CD4 cell count was 650.6 cells/mm3 among HIV-infected adolescents and young adults aged 10–24 years attending Kenyatta National Hospital comprehensive care center.

KenyaVIH/sidapublié 2021African health sciencesPubMeddocument de 5 observations